Comparison between Anondita Medicare IPO and B.A.G.Convergence IPO.
Anondita Medicare IPO is a SME Bookbuilding IPO proposed to list at NSE SME while B.A.G.Convergence IPO is a SME Bookbuilding proposed to list at NSE SME.
| Anondita Medicare IPO | B.A.G.Convergence IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Narnolia Financial Services Ltd. | Inventure Merchant Banker Services Pvt.Ltd. |
| Registrar | Maashitla Securities Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Mansi Share & Stock Broking Pvt.Ltd. | ACME Capital Market Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Anondita Medicare IPO is up to ₹65.58 Cr whereas the issue size of the B.A.G.Convergence IPO is up to ₹46.28 Cr. The final issue price of Anondita Medicare IPO is ₹145.00 per share and of B.A.G.Convergence IPO is ₹87.00 per share.
| Anondita Medicare IPO | B.A.G.Convergence IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹137.00 per share | ₹82.00 per share |
| Issue Price (Upper) | ₹145.00 per share | ₹87.00 per share |
| Issue Price (Final) | ₹145.00 per share | ₹87.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 1600 shares |
| Fresh Issue Size | 45,23,000 shares | 53,20,000 shares |
| Fresh Issue Size (Amount) | up to ₹65.58 Cr | up to ₹46.28 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 45,23,000 shares | 53,20,000 shares |
| Issue Size Total (Amount) | up to ₹65.58 Cr | up to ₹46.28 Cr |
Anondita Medicare IPO opens on Aug 22, 2025, while B.A.G.Convergence IPO opens on Sep 30, 2025. The closing date of Anondita Medicare IPO and B.A.G.Convergence IPO is Aug 26, 2025, and Oct 03, 2025, respectively.
| Anondita Medicare IPO | B.A.G.Convergence IPO | |
|---|---|---|
| Anchor Bid Date | Aug 21, 2025 | Sep 29, 2025 |
| Issue Open | Aug 22, 2025 | Sep 30, 2025 |
| Issue Close | Aug 26, 2025 | Oct 03, 2025 |
| Basis Of Allotment (Tentative) | Aug 28, 2025 | Oct 06, 2025 |
| Initiation of Refunds (Tentative) | Aug 29, 2025 | Oct 07, 2025 |
| Credit of Share (Tentative) | Aug 29, 2025 | Oct 07, 2025 |
| Listing date (Tentative) | Sep 01, 2025 | Oct 08, 2025 |
| Anchor Lockin End date 1 | Sep 27, 2025 | Nov 05, 2025 |
| Anchor Lockin End date 2 | Nov 26, 2025 | Jan 04, 2026 |
Anondita Medicare IPO P/E ratio is 11.74, as compared to B.A.G.Convergence IPO P/E ratio of 14.45.
| Anondita Medicare IPO | B.A.G.Convergence IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Anondita Medicare Ltd.'s revenue increased by 66% and profit after tax (PAT) rose by 327% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)B.A.G.Convergence Ltd.'s revenue increased by 18% and profit after tax (PAT) rose by 17% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.95 | 89.58 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.71 | 65.93 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.74 | 14.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹262.26 Cr. | ₹184.60 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 41.71 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 37.42 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.70 | 0.57 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹12.35 | ₹6.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 41.71 | 40.96 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Anondita Medicare IPO Retail Individual Investors (RII) are offered 15,86,000 shares while in B.A.G.Convergence IPO retail investors are offered 15,86,000 shares. Qualified Institutional Buyers (QIB) are offered 9,06,000 shares in Anondita Medicare IPO and 10,40,000 shares in B.A.G.Convergence IPO.
| Anondita Medicare IPO | B.A.G.Convergence IPO | |
|---|---|---|
| Anchor Investor Reservation | 13,50,000 shares | 15,60,000 shares |
| Market Maker Reservation | 2,70,000 shares | 2,80,000 shares |
| QIB | 9,06,000 shares | 10,40,000 shares |
| NII | 6,81,000 shares | 8,32,000 shares |
| RII | 15,86,000 shares | 18,88,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 45,23,000 shares | 53,20,000 shares |
Anondita Medicare IPO subscribed 300.89x in total, whereas B.A.G.Convergence IPO subscribed 1.38x.
| Anondita Medicare IPO | B.A.G.Convergence IPO | |
|---|---|---|
| QIB (times) | 153.03x | 1.38x |
| NII (times) | 531.82x | 2.63x |
| Big NII (times) | 641.02x | 3.63x |
| Small NII (times) | 313.43x | 0.62x |
| RII (times) | 286.20x | 0.83x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 300.89x | 1.38x |
